COMPANY

EnCompass Technologies

Profile checked Oct 10, 2026

Keywords: Aortic Stenosis Aortic Stenosis Treated With TAVI Aortic Diseases F2 Filter and Delivery System

Timeline

Sep 9, 2025 Trial start Not phased (device or behavioral study): Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR source ↗
2024-06 Trial start Not phased (device or behavioral study): U.S. Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR source ↗
Sep 12, 2023 Trial start Not phased (device or behavioral study): Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR source ↗
Apr 29, 2023 Trial start Early phase 1: Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR source ↗

2026-12 (ESTIMATED) · Not phased · Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR · NCT06689839

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06689839	Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR	Not phased (device or behavioral study)	Recruiting	Sep 9, 2025	2026-12 (estimated)
NCT05866640	Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR	Early phase 1	Recruiting	Apr 29, 2023	Dec 30, 2025 (estimated)
NCT06069661	U.S. Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR	Not phased (device or behavioral study)	Withdrawn	2024-06	2024-12 (estimated)
NCT05893082	Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR	Not phased (device or behavioral study)	Completed	Sep 12, 2023	Oct 31, 2024 (actual)